Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
100 hedge funds and large institutions have $142M invested in Calithera Biosciences, Inc in 2018 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 31 reducing their positions, and 23 closing their positions.
16% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 31
11% less funds holding
Funds holding: 112 → 100 (-12)
31% less capital invested
Capital invested by funds: $204M → $142M (-$62.4M)
42% less call options, than puts
Call options by funds: $536K | Put options by funds: $923K
43% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$11.1M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.6M |
| 3 |
BlackRock
New York
|
+$2.67M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.26M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$13.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$6.29M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.24M |
| 4 |
Millennium Management
New York
|
-$5.66M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.21M |
CALA Hedge Fund Activity: Q1 2018 in Review
100 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q1 2018, worth a combined $142M — down 31% from $204M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of CALA and 13 opened new positions — a net loss of 10 holders — while 31 trimmed existing stakes and 36 added.
The largest buyer was Federated Hermes, opening a new position worth an estimated $11.1M. The largest seller was Viking Global Investors, exiting entirely with an estimated $13.7M sold.
- 100 institutional investors held Calithera Biosciences, Inc (CALA) as of Q1 2018, down from 112 in Q4 2017.
- Funds reported $142M of Calithera Biosciences, Inc stock for Q1 2018, down 31% quarter-over-quarter.
- 13 funds opened new Calithera Biosciences, Inc positions in Q1 2018 and 23 closed out, a net change of -10 holders.
- The largest Calithera Biosciences, Inc buyer in Q1 2018 was Federated Hermes, an estimated $11.1M added.
- The largest Calithera Biosciences, Inc seller in Q1 2018 was Viking Global Investors, an estimated $13.7M sold.
Based on aggregated 13F filings for Q1 2018.